In a recent incident aboard a JetBlue flight, flight attendant Florence Chesson experienced a harrowing episode linked to a phenomenon known as “fume events.” After inhaling potentially toxic fumes, she reported sensations akin to having been drugged, which led to severe health repercussions. Her colleague also exhibited troubling symptoms, swiftly moving to the back of the aircraft, struggling to breathe, and subsequently requiring emergency assistance.
Chesson’s ordeal began on December 27, 2017, when she began experiencing debilitating symptoms, ultimately leading to a diagnosis of a traumatic brain injury and permanent nerve damage. Medical professionals, including neurologist Robert Kaniecki, likened her symptoms to those of a chemical concussion, reflecting the severity of her condition. Kaniecki noted that he had treated many individuals who have suffered brain injuries due to similar fume exposure incidents during flights.
These fume events occur due to a design flaw in most commercial jets, where air is drawn from the engines—known as “bleed air”—leading to potential contamination from oil, hydraulic fluid, and neurotoxins. An alarming report from the Wall Street Journal highlighted that incidents of fume events have surged in recent years, especially within the Airbus A320 family, the model Chesson was operating at the time of her incident.
Despite the growing number of reported events, aircraft manufacturers and airline operators have often downplayed health risks while resisting substantial regulatory changes. Leaks can release a cocktail of harmful substances that may lead to serious health issues, including emergency landings and impaired cognitive abilities during flights. Official reports describe fumes carrying various odors, likened to “wet dog” or “nail polish,” causing acute reactions among crew members and passengers alike.
Though official statements from the FAA maintain that these incidents are rare, analysis reveals that reported fume events from major U.S. airlines have more than doubled, with over 800 incidents occurring per million aircraft departures. Changes in reporting practices were acknowledged as contributing to the uptick, yet evidence suggests that the real figures could be even higher due to underreporting by crews.
Manufacturers Airbus and Boeing have acknowledged the potential for oil leaks but claim that the incidences are infrequent enough not to necessitate major changes. However, internal communications from industry personnel indicate a growing concern regarding the safety of cabin air and the potential for significant health risks associated with toxic exposure.
Chesson’s experience aligns with a larger narrative where aircrew members have faced repercussions for reporting health concerns related to fume events. Instances of pilots facing bullying for raising alarms about fumes highlight the ongoing tension between safety and operational pressures in the aviation industry.
Efforts to address these issues appear limited thus far, with some airlines beginning to implement minor changes. However, the overarching challenge remains—a lack of comprehensive regulatory frameworks to protect crew and passengers from the risks of toxic exposure in commercial aviation.
As the aviation industry continues to navigate these challenges, the health and safety of those working in and flying on commercial aircraft hangs in a delicate balance. The gravity of incidents like Chesson’s underscores an urgent need for proactive measures to safeguard both crew members and passengers from the potentially debilitating effects of contaminated cabin air.
